Operating Lease, Right-of-Use Asset of Roivant Sciences Ltd. from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Roivant Sciences Ltd. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2021 to 30 Sep 2025.
  • Roivant Sciences Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $85,136,000, a 98% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Roivant Sciences Ltd. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $85,136,000 +$42,159,000 +98% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q2
Q2 2025 $87,078,000 +$41,765,000 +92% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q1
Q1 2025 $89,021,000 +$45,019,000 +102% 31 Mar 2025 10-Q 10 Nov 2025 2025 Q2
Q4 2024 $90,895,000 +$43,997,000 +94% 31 Dec 2024 10-Q 10 Feb 2025 2024 Q3
Q3 2024 $42,977,000 -$5,652,000 -12% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q2
Q2 2024 $45,313,000 -$6,318,000 -12% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q1
Q1 2024 $44,002,000 -$9,249,000 -17% 31 Mar 2024 10-K 29 May 2025 2024 FY
Q4 2023 $46,898,000 -$7,738,000 -14% 31 Dec 2023 10-Q 13 Feb 2024 2023 Q3
Q3 2023 $48,629,000 -$4,460,000 -8.4% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q2
Q2 2023 $51,631,000 -$7,798,000 -13% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q1
Q1 2023 $53,251,000 -$7,793,000 -13% 31 Mar 2023 10-K 30 May 2024 2023 FY
Q4 2022 $54,636,000 -$7,046,000 -11% 31 Dec 2022 10-Q 13 Feb 2023 2022 Q3
Q3 2022 $53,089,000 -$10,109,000 -16% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q2
Q2 2022 $59,429,000 -$5,734,000 -8.8% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q1
Q1 2022 $61,044,000 -$1,235,000 -2% 31 Mar 2022 10-K 28 Jun 2023 2023 FY
Q4 2021 $61,682,000 31 Dec 2021 10-Q 14 Feb 2022 2021 Q3
Q3 2021 $63,198,000 30 Sep 2021 10-Q 15 Nov 2021 2021 Q2
Q2 2021 $65,163,000 30 Jun 2021 10-Q 21 Sep 2021 2021 Q1
Q1 2021 $62,279,000 31 Mar 2021 10-K 28 Jun 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.